About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

BMS-823778

Company: Bristol-Myers Squibb
Mechanism: Mechanism not yet reported
Route: Route not yet reported
Recruiting trials: None currently listed

Efficacy results: Not yet reported

No recruiting studies currently listed

See all studies for this drug

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Trial details

Completed NCT NCT01111955

Safety Study of BMS-823778 in Subjects With Type 2 Diabetes

Not yet reported Bristol-Myers Squibb 62 participants Est. completion 2011-01 14 sites

Type 2 diabetes
View official trial listing →
Completed NCT NCT01112423

Safety Study of BMS-823778 in Subjects With Hypercholesterolemia

Not yet reported Bristol-Myers Squibb 60 participants Est. completion 2010-12 12 sites Stand-alone

Other conditions: Dyslipidemia
View official trial listing →
Completed NCT NCT01515202

Japanese Phase 1 Multiple Ascending Dose Study

Not yet reported Bristol-Myers Squibb 40 participants Est. completion 2012-09 1 site Stand-alone

Type 2 diabetes
View official trial listing →
Terminated NCT NCT01602367

Safety and Efficacy Study of BMS-823778 to Treat Uncontrolled High Blood Pressure in Overweight and Obese Patients

Not yet reported Bristol-Myers Squibb 7 participants Est. completion 2012-11 35 sites Stand-alone

Other conditions: Hypertension
View official trial listing →
Withdrawn NCT NCT01666704

Proof of Concept Study of BMS-823778 to Assess the Effects on Atherosclerosis

Not yet reported Bristol-Myers Squibb Est. completion 2016-05 Stand-alone

Cardiovascular disease
View official trial listing →

Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

ClinicalTrials.gov — NCT01515202

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.